Invst LLC Makes New Investment in Celestica, Inc. $CLS

Key Points

• Invst LLC acquired 10,061 Celestica shares worth approximately $3.67 million in the second quarter. Institutional investors now own 67.38% of the company, including major new positions from Canada Pension Plan Investment Board and Legal & General Group.
• Celestica reported quarterly EPS of $2.54, exceeding the $2.29 consensus estimate, while revenue rose 62.4% year over year to $4.68 billion. The company issued fiscal 2026 EPS guidance of $11.30.
• Analysts maintain a bullish outlook, with a consensus “Buy” rating and average price target of $439.81. However, insiders sold 356,553 shares worth about $135.2 million over the past three months.

Invst LLC bought a new stake in shares of Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 10,061 shares of the technology company's stock, valued at approximately $3,670,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of CLS. Polar Asset Management Partners Inc. bought a new stake in shares of Celestica in the second quarter worth $335,000. Jupiter Topco LLC purchased a new position in Celestica in the second quarter worth about $2,774,000. Hsbc Holdings PLC purchased a new position in Celestica in the second quarter worth about $3,954,000. Canada Pension Plan Investment Board bought a new stake in shares of Celestica during the 2nd quarter valued at about $316,468,000. Finally, Legal & General Group Plc bought a new stake in shares of Celestica during the 2nd quarter valued at about $333,588,000. 67.38% of the stock is owned by institutional investors.

Celestica Trading Up 4.2%

Shares of CLS stock opened at $306.89 on Wednesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23. The stock has a fifty day simple moving average of $337.47 and a two-hundred day simple moving average of $335.71. The firm has a market capitalization of $35.29 billion, a PE ratio of 31.90 and a beta of 2.06. Celestica, Inc. has a 52-week low of $183.66 and a 52-week high of $474.02.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last announced its quarterly earnings data on Monday, July 27th. The technology company reported $2.54 EPS for the quarter, beating the consensus estimate of $2.29 by $0.25. The business had revenue of $4.68 billion for the quarter, compared to the consensus estimate of $4.30 billion. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The business's revenue was up 62.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.39 earnings per share. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. On average, analysts predict that Celestica, Inc. will post 10.15 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on CLS shares. Rothschild & Co Redburn began coverage on shares of Celestica in a report on Friday, May 1st. They set a "buy" rating and a $460.00 target price for the company. Citigroup upped their price objective on Celestica from $338.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, April 29th. Susquehanna raised their target price on Celestica from $460.00 to $510.00 and gave the stock a "positive" rating in a report on Wednesday, April 29th. Royal Bank Of Canada lifted their target price on Celestica from $440.00 to $450.00 and gave the company an "outperform" rating in a research report on Wednesday, July 29th. Finally, Canadian Imperial Bank of Commerce boosted their price target on Celestica from $480.00 to $500.00 and gave the company an "outperform" rating in a report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $439.81.

Insider Buying and Selling

In other Celestica news, CFO Mandeep Chawla sold 17,000 shares of the company's stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $399.65, for a total value of $6,794,050.00. Following the completion of the transaction, the chief financial officer directly owned 82,444 shares in the company, valued at $32,948,744.60. This represents a 17.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Robert Mionis sold 98,453 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total transaction of $36,328,172.47. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 356,553 shares of company stock worth $135,238,444. 1.10% of the stock is owned by insiders.

Celestica Company Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company's service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.